gatifloxacin has been researched along with Syncope in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999." | 5.32 | Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. ( Buxton, AE; Nicholson, WJ; Tammaro, D, 2003) |
| "Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999." | 1.32 | Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. ( Buxton, AE; Nicholson, WJ; Tammaro, D, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicholson, WJ | 1 |
| Buxton, AE | 1 |
| Tammaro, D | 1 |
| Lannini, PB | 1 |
| Circiumaru, I | 1 |
2 other studies available for gatifloxacin and Syncope
| Article | Year |
|---|---|
Bradycardic syncope in 2 patients who recently began gatifloxacin treatment.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bradycardia; Female; Fluoroquinolones; Gatifloxacin; | 2003 |
Gatifloxacin-induced QTc prolongation and ventricular tachycardia.
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Gatifloxacin; Humans; Long QT Syndrome; Synco | 2001 |